The Shareholders Foundation, Inc. announces that a deadline is coming up in the lawsuit for certain investors in shares of agilon health, inc. (NYSE: AGL). Investors, who purchased shares of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025 in excess of $100,000 have certain options and there are short and […]

Clinical progress, pipeline expansion, and operational momentum underpin leadership continuity as the Company advances into 2026 and beyond SEATTLE, WA / ACCESS Newswire / February 3, 2026 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced executive leadership transitions to

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has appointed Michael P. Miller to its Board of Directors. Mr. Miller has more than four decades of experience in commercial and leadership roles in the biotechnology and pharmaceutical industries. “Mike has a strong track record of commercial excellence, and we’re delighted to have him join

Leading Biospecimen Lifecycle Management Platform and Global CRO Formalize Collaboration Following Successful Pilot Slope, the only end-to-end, vendor-agnostic platform for managing biospecimens and lab kits, and CellCarta, a leading global contract research organization (CRO), today announced they have formalized their Kit Inventory Portal (KIP) collaboration. This follows a successful pilot program and positions Slope’s platform

Independent advisor joins Cetera for growth, marketing support and Commonwealth-like service Cetera has welcomed longtime independent financial advisor Neil Henning, who joins the firm after more than 23 years affiliated with Commonwealth Financial Network. Based in New Jersey and North Carolina, Henning and his Fortress Financial wealth management team oversee approximately $75 million in assets

SCIENTURE Provides Commercial Update on ARBLI(TM), the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium GlobeNewswire February 03, 2026 Company highlights accelerating access and revenue growth for ARBLI(TM) and confirms REZENOPY(TM) launch timeline, addressing a combined US annual losartan and naloxone market size of close to $385 million Outlines Q1 2026 outlook and reports significant

NordProtect launches Scam Protection bundle to shield Americans from rising online fraud GlobeNewswire February 03, 2026 LONDON, Feb. 03, 2026 (GLOBE NEWSWIRE) — In response to the rapidly increasing number of online fraud incidents, the identity theft protection service NordProtect today announced the launch of its new Scam Protection bundle, designed to enhance American users'

London, UK and Irvine, CA, Feb. 03, 2026 (GLOBE NEWSWIRE) — Kocho, a UK-based provider of cybersecurity, identity, cloud transformation and managed services announced today that it has selected Zadara, the sovereign AI cloud leader, to support and future-proof its cloud infrastructure. The collaboration equips Kocho with the secure infrastructure needed to meet growing client

Global Leaders to Explore Healthcare's Biggest Challenges at League Connect 2026 Today, League announced that Sol Rashidi, Steven Kotler, and Marc Priestley will be the featured keynote speakers at League Connect 2026. League Connect is an immersive conference for healthcare executives, hosted by League, the AI-driven healthcare CX platform. Each year, the invite-only event gathers

Zadara Empowers Kocho with Streamlined VMware Alternative to Eliminate Complexity and Multi-Tenant AI Clouds Powered by NVIDIA GPUs to Enable Efficient Sovereign AI Clouds Partnership enhances Kocho's agility and security while supporting data sovereignty, AI readiness and its Microsoft-first cloud strategy GlobeNewswire February 03, 2026 London, UK and Irvine, CA, Feb. 03, 2026 (GLOBE NEWSWIRE)